ONTOLOGY REPORT - ANNOTATIONS
| Term: | cell surface receptor signaling pathway |
|
| Accession: | GO:0007166
|
browse the term
|
| Definition: | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| Synonyms: | exact_synonym: | cell surface receptor linked signal transduction; cell surface receptor linked signaling pathway; cell surface receptor linked signalling pathway |
| | xref_analog: | Reactome:REACT_6290 |
|
|
cell surface receptor signaling pathway
|
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IDA |
19 |
54,738,556 |
54,750,349 |
RGD:625718 |
RGD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
IDA |
1 |
223,478,436 |
223,494,455 |
RGD:628365 |
RGD |
| G |
Btla |
B and T lymphocyte associated |
|
|
ISO |
11 |
57,102,004 |
57,123,067 |
RGD:1624291 |
RGD |
| G |
Cbl |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
|
|
IEA |
8 |
47,135,357 |
47,211,889 |
RGD:1600115 |
InterPro |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
|
IEA |
11 |
49,690,402 |
49,856,762 |
RGD:1600115 |
InterPro |
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
|
IEA |
1 |
79,091,412 |
79,108,189 |
RGD:1600115 |
InterPro |
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
IEA |
20 |
47,502,354 |
47,507,663 |
RGD:1600115 |
ENSEMBL |
| G |
Cd247 |
Cd247 molecule |
|
|
IDA |
13 |
81,515,383 |
81,594,699 |
RGD:634717 |
RGD |
| G |
Cd274 |
CD274 molecule |
|
|
IEA |
1 |
233,053,607 |
233,065,384 |
RGD:1600115 |
ENSEMBL |
| G |
Cd274 |
CD274 molecule |
|
|
ISO |
1 |
233,053,607 |
233,065,384 |
RGD:1624291 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:1624291 |
RGD |
| G |
Cd3d |
CD3 molecule, delta |
|
|
IEA |
8 |
47,932,151 |
47,936,744 |
RGD:1600115 |
InterPro |
| G |
Cd3e |
CD3 molecule, epsilon |
|
|
ISO |
8 |
47,947,257 |
47,958,419 |
RGD:1624291 |
RGD |
| G |
Cd3e |
CD3 molecule, epsilon |
|
|
ISO |
8 |
47,947,257 |
47,958,419 |
RGD:1624291 |
RGD |
| G |
Cd3g |
CD3 molecule, gamma |
|
|
ISO |
8 |
47,924,369 |
47,930,550 |
RGD:1624291 |
RGD |
| G |
Cd3g |
CD3 molecule, gamma |
|
|
IEA |
8 |
47,924,369 |
47,930,550 |
RGD:1600115 |
ENSEMBL |
| G |
Cd3g |
CD3 molecule, gamma |
|
|
ISS |
8 |
47,924,369 |
47,930,550 |
RGD:1600115 |
UniProtKB |
| G |
Cd4 |
Cd4 molecule |
|
|
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:1624291 |
RGD |
| G |
Cd4 |
Cd4 molecule |
|
|
IEA |
4 |
160,988,512 |
161,014,038 |
RGD:1600115 |
ENSEMBL |
| G |
Cd79a |
Cd79a molecule, immunoglobulin-associated alpha |
|
|
IEA |
1 |
80,189,446 |
80,205,354 |
RGD:1600115 |
InterPro |
| G |
Cd8a |
CD8a molecule |
|
|
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:1624291 |
RGD |
| G |
Cd8a |
CD8a molecule |
|
|
IEA |
4 |
104,589,922 |
104,594,159 |
RGD:1600115 |
ENSEMBL |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
|
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:1624291 |
RGD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
|
ISO |
9 |
81,910,656 |
82,036,998 |
RGD:1624291 |
RGD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
|
ISO |
9 |
73,510,488 |
73,511,537 |
RGD:1624291 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:1624291 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:1624291 |
RGD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
|
ISO |
X |
94,802,078 |
94,803,097 |
RGD:1624291 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:1624291 |
RGD |
| G |
Edn3 |
endothelin 3 |
|
|
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:1624291 |
RGD |
| G |
Edn3 |
endothelin 3 |
|
|
IEA |
3 |
166,491,368 |
166,514,051 |
RGD:1600115 |
ENSEMBL |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Epha1 |
Eph receptor A1 |
|
|
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:1624291 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:1624291 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:1624291 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
IEA |
3 |
76,005,318 |
76,018,603 |
RGD:1600115 |
ENSEMBL |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
IEA |
13 |
86,809,011 |
86,823,599 |
RGD:1600115 |
ENSEMBL |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
|
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:1624291 |
RGD |
| G |
Il12b |
interleukin 12B |
|
|
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:1624291 |
RGD |
| G |
Itgal |
integrin, alpha L |
|
|
ISO |
1 |
186,561,795 |
186,598,908 |
RGD:1624291 |
RGD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
|
ISO |
13 |
96,044,260 |
96,138,456 |
RGD:1624291 |
RGD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
|
IEA |
13 |
96,044,260 |
96,138,456 |
RGD:1600115 |
ENSEMBL |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
|
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:1624291 |
RGD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
|
IEA |
10 |
106,942,942 |
106,948,652 |
RGD:1600115 |
ENSEMBL |
| G |
Khdrbs1 |
KH domain containing, RNA binding, signal transduction associated 1 |
|
|
ISO |
5 |
148,801,685 |
148,802,351 |
RGD:1624291 |
RGD |
| G |
Khdrbs1 |
KH domain containing, RNA binding, signal transduction associated 1 |
|
|
ISO |
5 |
148,801,685 |
148,802,351 |
RGD:1624291 |
RGD |
| G |
Khdrbs1 |
KH domain containing, RNA binding, signal transduction associated 1 |
|
|
IDA |
5 |
148,801,685 |
148,802,351 |
|
UniProtKB |
| G |
L1cam |
L1 cell adhesion molecule |
|
|
ISO |
X |
159,784,792 |
159,801,553 |
RGD:1624291 |
RGD |
| G |
Lag3 |
lymphocyte-activation gene 3 |
|
|
ISO |
4 |
161,031,506 |
161,039,255 |
RGD:1624291 |
RGD |
| G |
Lag3 |
lymphocyte-activation gene 3 |
|
|
IEA |
4 |
161,031,506 |
161,039,255 |
RGD:1600115 |
ENSEMBL |
| G |
Lama1 |
laminin, alpha 1 |
|
|
ISO |
9 |
106,855,708 |
106,980,651 |
RGD:1624291 |
RGD |
| G |
Lama1 |
laminin, alpha 1 |
|
|
IEA |
9 |
106,855,708 |
106,980,651 |
RGD:1600115 |
ENSEMBL |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
|
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:1624291 |
RGD |
| G |
LOC100913063 |
B-cell antigen receptor complex-associated protein alpha chain-like |
|
|
IEA |
|
|
|
RGD:1600115 |
InterPro |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
|
IMP |
7 |
119,557,141 |
119,559,619 |
RGD:1624362 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:1624291 |
RGD |
| G |
Ms4a2 |
membrane-spanning 4-domains, subfamily A, member 2 |
|
|
ISO |
1 |
214,011,050 |
214,018,999 |
RGD:1624291 |
RGD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
|
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:1624291 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
|
ISO |
8 |
52,822,350 |
53,120,572 |
RGD:1624291 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
|
IEA |
8 |
52,822,350 |
53,120,572 |
RGD:1600115 |
ENSEMBL |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
|
IMP |
2 |
182,724,916 |
182,740,242 |
RGD:1580144 |
RGD |
| G |
Nup62 |
nucleoporin 62 |
|
|
ISO |
1 |
95,288,019 |
95,303,545 |
RGD:1624291 |
RGD |
| G |
Nup62 |
nucleoporin 62 |
|
|
ISS |
1 |
95,288,019 |
95,303,545 |
RGD:1600115 |
UniProtKB |
| G |
Ostn |
osteocrin |
|
|
ISO |
11 |
75,432,572 |
75,455,380 |
RGD:1624291 |
RGD |
| G |
Ostn |
osteocrin |
|
|
IEA |
11 |
75,432,572 |
75,455,380 |
RGD:1600115 |
ENSEMBL |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
IDA |
12 |
35,074,025 |
35,117,152 |
|
BHF-UCL |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
|
IMP |
3 |
54,292,076 |
54,319,242 |
RGD:1642700 |
RGD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
|
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:1624291 |
RGD |
| G |
Plxna2 |
plexin A2 |
|
|
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:1624291 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
IMP |
5 |
172,061,825 |
172,172,793 |
RGD:1642700 |
RGD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:1624291 |
RGD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISS |
15 |
45,589,222 |
45,717,866 |
RGD:1600115 |
UniProtKB |
| G |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
|
|
NAS |
10 |
62,500,853 |
62,576,593 |
RGD:1299553 |
RGD |
| G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
|
|
NAS |
3 |
68,098,435 |
68,113,874 |
RGD:1299553 |
RGD |
| G |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
|
|
ISO |
18 |
41,545,350 |
41,665,721 |
RGD:1624291 |
RGD |
| G |
Spn |
sialophorin |
|
|
ISO |
1 |
186,388,120 |
186,391,887 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
|
ISO |
8 |
34,966,856 |
34,969,727 |
RGD:1624291 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:1624291 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
ISS |
4 |
162,172,563 |
162,185,252 |
RGD:1600115 |
UniProtKB |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:1624291 |
RGD |
| G |
Tspan12 |
tetraspanin 12 |
|
|
ISO |
4 |
48,084,836 |
48,164,956 |
RGD:1624291 |
RGD |
| G |
Tspan12 |
tetraspanin 12 |
|
|
ISS |
4 |
48,084,836 |
48,164,956 |
RGD:1600115 |
UniProtKB |
| G |
Unc50 |
unc-50 homolog (C. elegans) |
|
|
IMP |
9 |
36,375,661 |
36,383,535 |
RGD:634436 |
UniProtKB |
| G |
Vldlr |
very low density lipoprotein receptor |
|
|
TAS |
1 |
230,666,736 |
230,697,748 |
RGD:1342463 |
RGD |
activation of transmembrane receptor protein tyrosine kinase activity
|
| G |
Angpt1 |
angiopoietin 1 |
|
|
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:1624291 |
RGD |
| G |
Angpt4 |
angiopoietin 4 |
|
|
ISO |
3 |
142,249,115 |
142,282,307 |
RGD:1624291 |
RGD |
| G |
Angpt4 |
angiopoietin 4 |
|
|
ISO |
3 |
142,249,115 |
142,282,307 |
RGD:1624291 |
RGD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
|
ISO |
8 |
58,570,223 |
58,583,594 |
RGD:1624291 |
RGD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
|
IEA |
8 |
58,570,223 |
58,583,594 |
RGD:1600115 |
ENSEMBL |
| G |
Nrg1 |
neuregulin 1 |
|
|
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:1624291 |
RGD |
| G |
Pdgfc |
platelet derived growth factor C |
|
|
ISO |
2 |
172,635,732 |
172,811,004 |
RGD:1624291 |
RGD |
| G |
Pdgfc |
platelet derived growth factor C |
|
|
IEA |
2 |
172,635,732 |
172,811,004 |
RGD:1600115 |
ENSEMBL |
| G |
Prlr |
prolactin receptor |
|
|
ISO |
2 |
59,507,966 |
59,701,221 |
RGD:1624291 |
RGD |
antigen receptor-mediated signaling pathway
|
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:1624291 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISS |
19 |
41,646,190 |
41,669,234 |
RGD:1600115 |
UniProtKB |
| G |
Lax1 |
lymphocyte transmembrane adaptor 1 |
|
|
ISO |
13 |
46,606,072 |
46,616,628 |
RGD:1624291 |
RGD |
| G |
Lax1 |
lymphocyte transmembrane adaptor 1 |
|
|
IEA |
13 |
46,606,072 |
46,616,628 |
RGD:1600115 |
ENSEMBL |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
ISO |
12 |
21,544,434 |
21,572,232 |
RGD:1624291 |
RGD |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
IEA |
12 |
21,544,434 |
21,572,232 |
RGD:1600115 |
ENSEMBL |
B cell receptor signaling pathway
|
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:1624291 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISS |
19 |
41,646,190 |
41,669,234 |
RGD:1600115 |
UniProtKB |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
IEA |
13 |
12,730,736 |
12,905,108 |
RGD:1600115 |
ENSEMBL |
| G |
Blk |
B lymphoid tyrosine kinase |
|
|
ISO |
15 |
42,643,847 |
42,682,793 |
RGD:1624291 |
RGD |
| G |
Blk |
B lymphoid tyrosine kinase |
|
|
IEA |
15 |
42,643,847 |
42,682,793 |
RGD:1600115 |
ENSEMBL |
| G |
Cd19 |
CD19 molecule |
|
|
ISO |
1 |
185,501,247 |
185,507,665 |
RGD:1624291 |
RGD |
| G |
Cd19 |
CD19 molecule |
|
|
IEA |
1 |
185,501,247 |
185,507,665 |
RGD:1600115 |
ENSEMBL |
| G |
Cd38 |
CD38 molecule |
|
|
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:1624291 |
RGD |
| G |
Cd38 |
CD38 molecule |
|
|
IEA |
14 |
72,320,479 |
72,360,329 |
RGD:1600115 |
ENSEMBL |
| G |
Cd79a |
Cd79a molecule, immunoglobulin-associated alpha |
|
|
ISO |
1 |
80,189,446 |
80,205,354 |
RGD:1624291 |
RGD |
| G |
Cd79a |
Cd79a molecule, immunoglobulin-associated alpha |
|
|
ISO |
1 |
80,189,446 |
80,205,354 |
RGD:1624291 |
RGD |
| G |
Cd79b |
Cd79b molecule, immunoglobulin-associated beta |
|
|
ISO |
10 |
95,703,129 |
95,706,275 |
RGD:1624291 |
RGD |
| G |
Cd79b |
Cd79b molecule, immunoglobulin-associated beta |
|
|
ISO |
10 |
95,703,129 |
95,706,275 |
RGD:1624291 |
RGD |
| G |
Cd79b |
Cd79b molecule, immunoglobulin-associated beta |
|
|
IEA |
10 |
95,703,129 |
95,706,275 |
RGD:1600115 |
ENSEMBL |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
|
ISO |
9 |
59,495,773 |
59,501,300 |
RGD:1624291 |
RGD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
|
IEA |
9 |
59,495,773 |
59,501,300 |
RGD:1600115 |
ENSEMBL |
| G |
Klhl6 |
kelch-like family member 6 |
|
|
ISO |
11 |
83,221,776 |
83,260,528 |
RGD:1624291 |
RGD |
| G |
Klhl6 |
kelch-like family member 6 |
|
|
IEA |
11 |
83,221,776 |
83,260,528 |
RGD:1600115 |
ENSEMBL |
| G |
Lat2 |
linker for activation of T cells family, member 2 |
|
|
IEA |
12 |
23,174,554 |
23,180,908 |
RGD:1600115 |
ENSEMBL |
| G |
Lat2 |
linker for activation of T cells family, member 2 |
|
|
ISO |
12 |
23,174,554 |
23,180,908 |
RGD:1624291 |
RGD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
|
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:1624291 |
RGD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
|
IEA |
5 |
148,707,505 |
148,718,296 |
RGD:1600115 |
ENSEMBL |
| G |
Lime1 |
Lck interacting transmembrane adaptor 1 |
|
|
ISO |
3 |
170,522,420 |
170,524,743 |
RGD:1624291 |
RGD |
| G |
Lime1 |
Lck interacting transmembrane adaptor 1 |
|
|
IEA |
3 |
170,522,420 |
170,524,743 |
RGD:1600115 |
ENSEMBL |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
IEA |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
ENSEMBL |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:1624291 |
RGD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
IEA |
11 |
85,968,732 |
86,030,387 |
RGD:1600115 |
ENSEMBL |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:1624291 |
RGD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
ISS |
2 |
12,331,078 |
12,346,520 |
RGD:1600115 |
UniProtKB |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
IEA |
2 |
12,331,078 |
12,346,520 |
RGD:1600115 |
ENSEMBL |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
ISO |
7 |
142,351,954 |
142,397,045 |
RGD:1624291 |
RGD |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
IEA |
7 |
142,351,954 |
142,397,045 |
RGD:1600115 |
ENSEMBL |
| G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
|
|
ISO |
7 |
121,019,642 |
121,038,935 |
RGD:1624291 |
RGD |
| G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
|
|
IEA |
7 |
121,019,642 |
121,038,935 |
RGD:1600115 |
ENSEMBL |
| G |
Nfatc2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
|
ISO |
3 |
159,656,032 |
159,773,643 |
RGD:1624291 |
RGD |
| G |
Nfatc2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
|
IEA |
3 |
159,656,032 |
159,773,643 |
RGD:1600115 |
ENSEMBL |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
|
ISO |
19 |
47,875,572 |
47,947,573 |
RGD:1624291 |
RGD |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
|
IEA |
1 |
190,187,202 |
190,238,309 |
RGD:1600115 |
ENSEMBL |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
|
ISO |
1 |
190,187,202 |
190,238,309 |
RGD:1624291 |
RGD |
| G |
Prkcb |
protein kinase C, beta |
|
|
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:1624291 |
RGD |
| G |
Prkcb |
protein kinase C, beta |
|
|
IEA |
1 |
181,117,512 |
181,459,856 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcb |
protein kinase C, beta |
|
|
ISS |
1 |
181,117,512 |
181,459,856 |
RGD:1600115 |
UniProtKB |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:1624291 |
RGD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
IEA |
4 |
160,843,699 |
160,868,856 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISS |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
UniProtKB |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISS |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
UniProtKB |
| G |
Tec |
tec protein tyrosine kinase |
|
|
ISO |
14 |
37,756,486 |
37,865,180 |
RGD:1624291 |
RGD |
| G |
Tec |
tec protein tyrosine kinase |
|
|
IEA |
14 |
37,756,486 |
37,865,180 |
RGD:1600115 |
ENSEMBL |
| G |
Vav3 |
vav 3 guanine nucleotide exchange factor |
|
|
ISO |
2 |
204,982,222 |
205,326,505 |
RGD:1624291 |
RGD |
brain-derived neurotrophic factor receptor signaling pathway
|
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IMP |
17 |
11,494,463 |
11,811,654 |
RGD:1626132 |
RGD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
ISO |
17 |
11,494,463 |
11,811,654 |
RGD:1624291 |
RGD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
ISO |
17 |
11,494,463 |
11,811,654 |
RGD:1624291 |
RGD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IDA |
17 |
11,494,463 |
11,811,654 |
|
UniProtKB |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
|
IDA |
17 |
11,494,463 |
11,811,654 |
|
UniProtKB |
| G |
Tiam1 |
T-cell lymphoma invasion and metastasis 1 |
|
|
ISO |
11 |
30,123,752 |
30,252,936 |
RGD:1624291 |
RGD |
cell surface pattern recognition receptor signaling pathway
|
| G |
Clec7a |
C-type lectin domain family 7, member A |
|
|
ISO |
4 |
166,723,515 |
166,734,681 |
RGD:1624291 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:1624291 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEA |
2 |
175,607,990 |
175,613,992 |
RGD:1600115 |
ENSEMBL |
collagen-activated tyrosine kinase receptor signaling pathway
|
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
|
ISO |
20 |
3,194,265 |
3,214,611 |
RGD:1624291 |
RGD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
|
ISO |
20 |
3,194,265 |
3,214,611 |
RGD:1624291 |
RGD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
|
ISO |
20 |
3,194,265 |
3,214,611 |
RGD:1624291 |
RGD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
|
ISO |
20 |
3,194,265 |
3,214,611 |
RGD:1624291 |
RGD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
|
ISS |
20 |
3,194,265 |
3,214,611 |
RGD:1600115 |
UniProtKB |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
|
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:1624291 |
RGD |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
|
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:1624291 |
RGD |
complement component C5a signaling pathway
|
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
TAS |
|
|
|
RGD:70320 |
GOC |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
IDA |
|
|
|
RGD:727626 |
GOC |
complement receptor mediated signaling pathway
|
| G |
C3ar1 |
complement component 3a receptor 1 |
|
|
IMP |
4 |
159,326,402 |
159,333,433 |
RGD:2303017 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
IMP |
|
|
|
RGD:2303017 |
RGD |
| G |
Cr2 |
complement component (3d/Epstein Barr virus) receptor 2 |
|
|
ISO |
13 |
111,078,338 |
111,113,667 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
IEA |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
ENSEMBL |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISS |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
UniProtKB |
enzyme linked receptor protein signaling pathway
|
| G |
Axl |
Axl receptor tyrosine kinase |
|
|
IGI |
1 |
80,964,751 |
80,994,300 |
RGD:2290270 |
MGI |
| G |
Axl |
Axl receptor tyrosine kinase |
|
|
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:1624291 |
RGD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
|
IEA |
1 |
80,964,751 |
80,994,300 |
RGD:1600115 |
ENSEMBL |
| G |
Gas6 |
growth arrest specific 6 |
|
|
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:1624291 |
RGD |
| G |
Gas6 |
growth arrest specific 6 |
|
|
IEA |
16 |
80,900,159 |
80,930,929 |
RGD:1600115 |
ENSEMBL |
| G |
Jak1 |
Janus kinase 1 |
|
|
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:1624291 |
RGD |
| G |
Jak1 |
Janus kinase 1 |
|
|
IEA |
5 |
121,804,586 |
121,905,581 |
RGD:1600115 |
ENSEMBL |
| G |
Jak2 |
Janus kinase 2 |
|
|
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISS |
16 |
18,878,139 |
18,889,441 |
RGD:1600115 |
BHF-UCL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
epidermal growth factor catabolic process
|
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
|
ISO |
4 |
122,202,685 |
122,220,649 |
RGD:1624291 |
RGD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
|
IEA |
4 |
122,202,685 |
122,220,649 |
RGD:1600115 |
ENSEMBL |
epidermal growth factor receptor signaling pathway
|
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:1624291 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
IEA |
6 |
41,882,432 |
41,930,755 |
RGD:1600115 |
ENSEMBL |
| G |
Areg |
amphiregulin |
|
|
IDA |
14 |
18,466,313 |
18,475,571 |
RGD:1578718 |
RGD |
| G |
Areg |
amphiregulin |
|
|
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:1624291 |
RGD |
| G |
Arf4 |
ADP-ribosylation factor 4 |
|
|
IDA |
16 |
1,955,745 |
1,972,321 |
RGD:728363 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
IDA |
19 |
41,646,190 |
41,669,234 |
|
UniProtKB |
| G |
Btc |
betacellulin |
|
|
IDA |
14 |
18,194,470 |
18,235,228 |
RGD:2324625 |
RGD |
| G |
Camlg |
calcium modulating ligand |
|
|
ISO |
17 |
15,033,873 |
15,044,699 |
RGD:1624291 |
RGD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
|
ISO |
14 |
109,733,625 |
109,828,630 |
RGD:1624291 |
RGD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
|
ISS |
14 |
109,733,625 |
109,828,630 |
RGD:1600115 |
UniProtKB |
| G |
Egf |
epidermal growth factor |
|
|
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:1624291 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:1624291 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:1624291 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
IDA |
2 |
227,103,900 |
227,195,062 |
RGD:1626483 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
IDA |
14 |
97,617,358 |
97,788,211 |
RGD:70386 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:1624291 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
IMP |
14 |
97,617,358 |
97,788,211 |
RGD:1581908 |
RGD |
| G |
Ereg |
epiregulin |
|
|
ISO |
14 |
18,521,069 |
18,534,844 |
RGD:1624291 |
RGD |
| G |
Ereg |
epiregulin |
|
|
ISS |
14 |
18,521,069 |
18,534,844 |
RGD:1600115 |
UniProtKB |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:1624291 |
RGD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
IEA |
19 |
28,980,284 |
29,088,877 |
RGD:1600115 |
ENSEMBL |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
|
TAS |
18 |
29,143,567 |
29,153,944 |
RGD:728846 |
RGD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
|
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:1624291 |
RGD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
|
IMP |
18 |
29,143,567 |
29,153,944 |
RGD:1581908 |
RGD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
|
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:1624291 |
RGD |
| G |
Kif16b |
kinesin family member 16B |
|
|
IEA |
3 |
130,967,515 |
131,250,402 |
RGD:1600115 |
ENSEMBL |
| G |
Kif16b |
kinesin family member 16B |
|
|
ISO |
3 |
130,967,515 |
131,250,402 |
RGD:1624291 |
RGD |
| G |
Nrg2 |
neuregulin 2 |
|
|
IDA |
18 |
28,650,097 |
28,828,772 |
RGD:1304015 |
RGD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
IMP |
15 |
45,589,222 |
45,717,866 |
RGD:1642613 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
ISO |
6 |
10,552,177 |
10,582,783 |
RGD:1624291 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
IEA |
6 |
10,552,177 |
10,582,783 |
RGD:1600115 |
ENSEMBL |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
|
IDA |
10 |
102,392,187 |
102,394,256 |
RGD:2290270 |
UniProtKB |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
|
ISS |
10 |
102,392,187 |
102,394,256 |
RGD:1600115 |
UniProtKB |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
|
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:1624291 |
RGD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IEP |
3 |
148,157,256 |
148,170,524 |
RGD:1581134 |
RGD |
| G |
Tdgf1 |
teratocarcinoma-derived growth factor 1 |
|
NOT |
ISO |
8 |
115,341,587 |
115,346,871 |
RGD:1624291 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
TAS |
4 |
120,355,649 |
120,437,772 |
RGD:1578565 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
UniProtKB |
| G |
Vil1 |
villin 1 |
|
|
ISO |
9 |
73,748,632 |
73,776,347 |
RGD:1624291 |
RGD |
| G |
Vil1 |
villin 1 |
|
|
IEA |
9 |
73,748,632 |
73,776,347 |
RGD:1600115 |
ENSEMBL |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway
|
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:1624291 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
IEA |
6 |
41,882,432 |
41,930,755 |
RGD:1600115 |
ENSEMBL |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:1624291 |
RGD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
|
IEA |
3 |
114,867,357 |
114,869,680 |
RGD:1600115 |
ENSEMBL |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
|
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:1624291 |
RGD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
|
IEA |
14 |
81,107,907 |
81,109,610 |
RGD:1600115 |
ENSEMBL |
ERBB signaling pathway
|
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:1624291 |
RGD |
| G |
Mvp |
major vault protein |
|
|
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:1624291 |
RGD |
| G |
Nrg1 |
neuregulin 1 |
|
|
IEA |
16 |
63,937,796 |
64,126,183 |
RGD:1600115 |
ENSEMBL |
| G |
Nrg1 |
neuregulin 1 |
|
|
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:1624291 |
RGD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
|
ISO |
12 |
36,501,886 |
36,558,055 |
RGD:1624291 |
RGD |
Fc receptor mediated inhibitory signaling pathway
|
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
Fc receptor mediated stimulatory signaling pathway
|
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
Fc receptor signaling pathway
|
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IEA |
14 |
34,906,043 |
34,984,819 |
RGD:1600115 |
ENSEMBL |
Fc-epsilon receptor signaling pathway
|
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
Fc-gamma receptor signaling pathway
|
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr2a |
Fc fragment of IgG, low affinity IIa, receptor |
|
|
IDA |
13 |
86,898,651 |
86,911,743 |
RGD:728376 |
GOC |
| G |
Fcgrt |
Fc fragment of IgG, receptor, transporter, alpha |
|
|
TAS |
1 |
95,566,717 |
95,575,645 |
RGD:728556 |
GOC |
fibroblast growth factor receptor signaling pathway
|
| G |
Cep57 |
centrosomal protein 57 |
|
|
IEA |
8 |
10,608,688 |
10,627,914 |
RGD:1600115 |
ENSEMBL |
| G |
Cep57 |
centrosomal protein 57 |
|
|
ISO |
8 |
10,608,688 |
10,627,914 |
RGD:1624291 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:1624291 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEA |
1 |
21,327,099 |
21,330,215 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:1624291 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:1624291 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:1624291 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:1624291 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
IEA |
18 |
31,785,480 |
31,806,452 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
TAS |
2 |
50,866,799 |
50,940,319 |
RGD:727503 |
RGD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
NOT |
ISO |
11 |
74,208,696 |
74,481,037 |
RGD:1624291 |
RGD |
| G |
Fgf14 |
fibroblast growth factor 14 |
|
NOT |
ISO |
15 |
109,057,275 |
109,297,945 |
RGD:1624291 |
RGD |
| G |
Fgf16 |
fibroblast growth factor 16 |
|
|
IGI |
X |
93,870,484 |
93,880,067 |
|
MGI |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
|
ISO |
15 |
51,038,529 |
51,044,118 |
RGD:1624291 |
RGD |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
|
IEA |
15 |
51,038,529 |
51,044,118 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf18 |
fibroblast growth factor 18 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Fgf18 |
fibroblast growth factor 18 |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Fgf19 |
fibroblast growth factor 19 |
|
|
ISO |
1 |
205,324,890 |
205,328,178 |
RGD:1624291 |
RGD |
| G |
Fgf19 |
fibroblast growth factor 19 |
|
|
ISO |
1 |
205,324,890 |
205,328,178 |
RGD:1624291 |
RGD |
| G |
Fgf19 |
fibroblast growth factor 19 |
|
|
IEA |
1 |
205,324,890 |
205,328,178 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:1624291 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:1624291 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:1624291 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:1624291 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IPI |
2 |
123,893,314 |
123,947,136 |
|
MGI |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IPI |
2 |
123,893,314 |
123,947,136 |
|
MGI |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IPI |
2 |
123,893,314 |
123,947,136 |
|
MGI |
| G |
Fgf20 |
fibroblast growth factor 20 |
|
|
IDA |
16 |
55,386,987 |
55,393,744 |
|
MGI |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
|
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:1624291 |
RGD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
|
ISO |
1 |
205,269,480 |
205,273,404 |
RGD:1624291 |
RGD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
|
ISO |
1 |
205,269,480 |
205,273,404 |
RGD:1624291 |
RGD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
|
IEA |
1 |
205,269,480 |
205,273,404 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
|
IEA |
1 |
205,269,480 |
205,273,404 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
|
ISO |
1 |
205,292,272 |
205,293,705 |
RGD:1624291 |
RGD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
|
ISO |
1 |
205,292,272 |
205,293,705 |
RGD:1624291 |
RGD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
|
ISO |
14 |
12,713,971 |
12,734,634 |
RGD:1624291 |
RGD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
|
ISO |
14 |
12,713,971 |
12,734,634 |
RGD:1624291 |
RGD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
|
IEA |
14 |
12,713,971 |
12,734,634 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf6 |
fibroblast growth factor 6 |
|
|
ISO |
4 |
163,403,896 |
163,412,431 |
RGD:1624291 |
RGD |
| G |
Fgf6 |
fibroblast growth factor 6 |
|
|
IEA |
4 |
163,403,896 |
163,412,431 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
|
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:1624291 |
RGD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
|
IEA |
3 |
113,468,427 |
113,517,538 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:1624291 |
RGD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:1624291 |
RGD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:1624291 |
RGD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:1624291 |
RGD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
IEA |
1 |
250,951,023 |
250,956,730 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
IEA |
1 |
250,951,023 |
250,956,730 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
|
IDA |
15 |
37,115,068 |
37,155,652 |
RGD:1304345 |
RGD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
|
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:1624291 |
RGD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
|
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:1624291 |
RGD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
|
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:1624291 |
RGD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
|
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISS |
16 |
70,869,974 |
70,910,045 |
RGD:1600115 |
UniProtKB |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
IMP |
1 |
189,482,975 |
189,589,279 |
RGD:2289848 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
IDA |
1 |
189,482,975 |
189,589,279 |
RGD:6480435 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
IDA |
14 |
82,683,191 |
82,697,229 |
RGD:1304345 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
IPI |
17 |
15,512,144 |
15,527,348 |
|
MGI |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
IPI |
17 |
15,512,144 |
15,527,348 |
|
MGI |
| G |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
|
|
ISO |
14 |
1,550,894 |
1,562,953 |
RGD:1624291 |
RGD |
| G |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
|
|
ISO |
14 |
1,550,894 |
1,562,953 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
IEA |
7 |
56,409,863 |
56,490,535 |
RGD:1600115 |
ENSEMBL |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Frs3 |
fibroblast growth factor receptor substrate 3 |
|
|
ISO |
9 |
8,754,714 |
8,761,537 |
RGD:1624291 |
RGD |
| G |
Frs3 |
fibroblast growth factor receptor substrate 3 |
|
|
IEA |
9 |
8,754,714 |
8,761,537 |
RGD:1600115 |
ENSEMBL |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
|
ISO |
10 |
105,722,014 |
105,818,649 |
RGD:1624291 |
RGD |
| G |
Kif16b |
kinesin family member 16B |
|
|
ISO |
3 |
130,967,515 |
131,250,402 |
RGD:1624291 |
RGD |
| G |
Kif16b |
kinesin family member 16B |
|
|
IEA |
3 |
130,967,515 |
131,250,402 |
RGD:1600115 |
ENSEMBL |
| G |
Klb |
klotho beta |
|
|
ISO |
14 |
45,598,875 |
45,650,432 |
RGD:1624291 |
RGD |
| G |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
|
ISO |
18 |
56,638,891 |
56,677,831 |
RGD:1624291 |
RGD |
| G |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
|
IEA |
18 |
56,638,891 |
56,677,831 |
RGD:1600115 |
ENSEMBL |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
|
ISO |
3 |
14,245,693 |
14,255,984 |
RGD:1624291 |
RGD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
|
IEA |
3 |
14,245,693 |
14,255,984 |
RGD:1600115 |
ENSEMBL |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
|
ISS |
3 |
14,245,693 |
14,255,984 |
RGD:1600115 |
UniProtKB |
| G |
Sos1 |
Son of sevenless homolog 1 (Drosophila) |
|
|
ISO |
6 |
3,308,778 |
3,390,661 |
RGD:1624291 |
RGD |
| G |
Trim71 |
tripartite motif containing 71, E3 ubiquitin protein ligase |
|
|
ISS |
8 |
118,905,817 |
118,972,365 |
RGD:1600115 |
UniProtKB |
| G |
Trim71 |
tripartite motif containing 71, E3 ubiquitin protein ligase |
|
|
ISO |
8 |
118,905,817 |
118,972,365 |
RGD:1624291 |
RGD |
fibroblast growth factor receptor signaling pathway involved in hemopoiesis
|
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
fibroblast growth factor receptor signaling pathway involved in mammary gland specification
|
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:1624291 |
RGD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:1624291 |
RGD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
|
IEA |
2 |
50,866,799 |
50,940,319 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
IEA |
1 |
189,482,975 |
189,589,279 |
RGD:1600115 |
ENSEMBL |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow
|
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation
|
| G |
Nog |
noggin |
|
|
ISO |
10 |
77,689,244 |
77,690,871 |
RGD:1624291 |
RGD |
| G |
Nog |
noggin |
|
|
IEA |
10 |
77,689,244 |
77,690,871 |
RGD:1600115 |
ENSEMBL |
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
|
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
IEA |
16 |
70,869,974 |
70,910,045 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow
|
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
glial cell-derived neurotrophic factor receptor signaling pathway
|
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
|
IDA |
15 |
51,279,770 |
51,371,053 |
RGD:632689 |
GOC |
| G |
Gfra4 |
GDNF family receptor alpha 4 |
|
|
IDA |
3 |
118,712,252 |
118,714,773 |
RGD:727298 |
GOC |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
IEA |
5 |
5,582,896 |
5,748,106 |
RGD:1600115 |
ENSEMBL |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISS |
5 |
5,582,896 |
5,748,106 |
RGD:1600115 |
UniProtKB |
| G |
Sulf2 |
sulfatase 2 |
|
|
ISO |
3 |
157,197,256 |
157,298,389 |
RGD:1624291 |
RGD |
| G |
Sulf2 |
sulfatase 2 |
|
|
IEA |
3 |
157,197,256 |
157,298,389 |
RGD:1600115 |
ENSEMBL |
immune response-activating cell surface receptor signaling pathway
|
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
|
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:1624291 |
RGD |
immune response-inhibiting cell surface receptor signaling pathway
|
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
immune response-regulating cell surface receptor signaling pathway
|
| G |
Btla |
B and T lymphocyte associated |
|
|
ISO |
11 |
57,102,004 |
57,123,067 |
RGD:1624291 |
RGD |
| G |
Btla |
B and T lymphocyte associated |
|
|
IEA |
11 |
57,102,004 |
57,123,067 |
RGD:1600115 |
ENSEMBL |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
IDA |
3 |
156,092,602 |
156,107,427 |
RGD:2290270 |
MGI |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:1624291 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
IEA |
3 |
156,092,602 |
156,107,427 |
RGD:1600115 |
ENSEMBL |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
| G |
Vav1 |
vav 1 guanine nucleotide exchange factor |
|
|
IEP |
|
|
|
RGD:2306006 |
RGD |
insulin receptor signaling pathway
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IMP |
6 |
137,640,482 |
137,657,552 |
|
UniProtKB |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISS |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
UniProtKB |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:1624291 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:1624291 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
IDA |
19 |
41,646,190 |
41,669,234 |
|
UniProtKB |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
|
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:1624291 |
RGD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
|
IEA |
16 |
69,110,522 |
69,123,895 |
RGD:1600115 |
ENSEMBL |
| G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
|
ISO |
20 |
29,562,634 |
29,579,209 |
RGD:1624291 |
RGD |
| G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
|
IEA |
20 |
29,562,634 |
29,579,209 |
RGD:1600115 |
ENSEMBL |
| G |
Foxc2 |
forkhead box C2 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Foxc2 |
forkhead box C2 |
|
|
IBA |
|
|
|
RGD:1600115 |
RefGenome |
| G |
Foxo1 |
forkhead box O1 |
|
|
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:1624291 |
RGD |
| G |
Foxo1 |
forkhead box O1 |
|
|
IBA |
2 |
141,127,345 |
141,203,446 |
RGD:1600115 |
RefGenome |
| G |
Foxo3 |
forkhead box O3 |
|
|
IBA |
20 |
46,171,784 |
46,262,818 |
RGD:1600115 |
RefGenome |
| G |
Foxo4 |
forkhead box O4 |
|
|
ISO |
X |
89,332,278 |
89,338,835 |
RGD:1624291 |
RGD |
| G |
Foxo4 |
forkhead box O4 |
|
|
IBA |
X |
89,332,278 |
89,338,835 |
RGD:1600115 |
RefGenome |
| G |
Foxo6 |
forkhead box O6 |
|
|
IBA |
5 |
140,846,863 |
140,866,841 |
RGD:1600115 |
RefGenome |
| G |
Foxs1 |
forkhead box S1 |
|
|
IBA |
3 |
143,272,507 |
143,273,776 |
RGD:1600115 |
RefGenome |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
IEA |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
ENSEMBL |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISS |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
UniProtKB |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
|
IDA |
14 |
92,814,797 |
92,911,442 |
|
BHF-UCL |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
|
IDA |
3 |
46,832,380 |
46,952,670 |
RGD:61620 |
RGD |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
|
ISO |
10 |
105,722,014 |
105,818,649 |
RGD:1624291 |
RGD |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
|
IEA |
10 |
105,722,014 |
105,818,649 |
RGD:1600115 |
ENSEMBL |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
|
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:1624291 |
RGD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
|
IEA |
1 |
80,505,517 |
80,514,139 |
RGD:1600115 |
ENSEMBL |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
|
IEP |
14 |
87,950,222 |
87,955,289 |
RGD:729306 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
IEA |
1 |
202,935,548 |
202,936,379 |
RGD:1600115 |
ENSEMBL |
| G |
Insr |
insulin receptor |
|
|
IMP |
12 |
2,934,967 |
3,087,691 |
RGD:1580595 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IDA |
12 |
2,934,967 |
3,087,691 |
RGD:1299201 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IEA |
9 |
81,585,251 |
81,638,071 |
RGD:1600115 |
ENSEMBL |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IDA |
9 |
81,585,251 |
81,638,071 |
|
BHF-UCL |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
IMP |
16 |
83,379,987 |
83,404,220 |
RGD:1299201 |
RGD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:1624291 |
RGD |
| G |
Irs4 |
insulin receptor substrate 4 |
|
|
NAS |
X |
36,881,414 |
36,885,105 |
RGD:2301084 |
RGD |
| G |
LOC259246 |
alpha-2u globulin PGCL1 |
|
|
ISS |
5 |
78,707,324 |
78,710,745 |
RGD:1600115 |
GOC |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
NOT |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:1624291 |
RGD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
|
IEP |
3 |
75,542,211 |
75,550,793 |
RGD:625467 |
RGD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
|
ISS |
10 |
83,710,448 |
83,724,973 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
IEA |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:1624291 |
RGD |
| G |
Phip |
pleckstrin homology domain interacting protein |
|
|
ISO |
8 |
88,009,896 |
88,060,553 |
RGD:1624291 |
RGD |
| G |
Phip |
pleckstrin homology domain interacting protein |
|
|
IEA |
8 |
88,009,896 |
88,060,553 |
RGD:1600115 |
ENSEMBL |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
|
IMP |
2 |
32,602,673 |
32,675,350 |
RGD:1625251 |
RGD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
|
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:1624291 |
RGD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
|
ISS |
2 |
32,602,673 |
32,675,350 |
RGD:1600115 |
UniProtKB |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
|
ISO |
5 |
136,497,494 |
136,566,473 |
RGD:1624291 |
RGD |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
|
IEA |
5 |
136,497,494 |
136,566,473 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcz |
protein kinase C, zeta |
|
|
IMP |
5 |
172,061,825 |
172,172,793 |
RGD:1642671 |
RGD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
|
ISO |
3 |
159,070,473 |
159,116,792 |
RGD:1624291 |
RGD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
|
IEA |
3 |
159,070,473 |
159,116,792 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
|
|
ISO |
18 |
64,205,920 |
64,271,288 |
RGD:1624291 |
RGD |
| G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
|
|
IEA |
18 |
64,205,920 |
64,271,288 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
|
|
ISO |
3 |
118,061,713 |
118,171,300 |
RGD:1624291 |
RGD |
| G |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
|
|
IEA |
3 |
118,061,713 |
118,171,300 |
RGD:1600115 |
ENSEMBL |
| G |
Rhoq |
ras homolog family member Q |
|
|
ISO |
6 |
10,414,042 |
10,449,472 |
RGD:1624291 |
RGD |
| G |
Rhoq |
ras homolog family member Q |
|
|
IEA |
6 |
10,414,042 |
10,449,472 |
RGD:1600115 |
ENSEMBL |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
ISO |
12 |
21,544,434 |
21,572,232 |
RGD:1624291 |
RGD |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
IEA |
12 |
21,544,434 |
21,572,232 |
RGD:1600115 |
ENSEMBL |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IDA |
2 |
181,616,581 |
181,628,144 |
|
BHF-UCL |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IMP |
2 |
181,616,581 |
181,628,144 |
|
BHF-UCL |
| G |
Slc2a8 |
solute carrier family 2, (facilitated glucose transporter) member 8 |
|
|
ISO |
3 |
11,962,570 |
11,972,115 |
RGD:1624291 |
RGD |
| G |
Slc2a8 |
solute carrier family 2, (facilitated glucose transporter) member 8 |
|
|
IEA |
3 |
11,962,570 |
11,972,115 |
RGD:1600115 |
ENSEMBL |
| G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
|
ISO |
8 |
114,484,491 |
114,609,850 |
RGD:1624291 |
RGD |
| G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
|
IEA |
8 |
114,484,491 |
114,609,850 |
RGD:1600115 |
ENSEMBL |
| G |
Socs7 |
suppressor of cytokine signaling 7 |
|
|
ISO |
10 |
86,090,339 |
86,134,313 |
RGD:1624291 |
RGD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
|
ISO |
1 |
245,419,532 |
245,527,846 |
RGD:1624291 |
RGD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
|
ISS |
1 |
245,419,532 |
245,527,846 |
RGD:1600115 |
UniProtKB |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
IEA |
10 |
46,461,684 |
46,483,646 |
RGD:1600115 |
ENSEMBL |
| G |
Stxbp4 |
syntaxin binding protein 4 |
|
|
ISO |
10 |
78,887,817 |
79,039,618 |
RGD:1624291 |
RGD |
| G |
Wdr6 |
WD repeat domain 6 |
|
|
NAS |
8 |
113,618,341 |
113,624,757 |
RGD:2301084 |
RGD |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade
|
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:1624291 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEA |
1 |
202,906,624 |
202,915,231 |
RGD:1600115 |
ENSEMBL |
Kit signaling pathway
|
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
natural killer cell inhibitory signaling pathway
|
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
ISO |
13 |
86,096,465 |
86,126,881 |
RGD:1624291 |
RGD |
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
IEA |
13 |
86,096,465 |
86,126,881 |
RGD:1600115 |
ENSEMBL |
negative regulation of B cell receptor signaling pathway
|
| G |
Lpxn |
leupaxin |
|
|
ISO |
1 |
215,885,954 |
215,920,253 |
RGD:1624291 |
RGD |
| G |
Lpxn |
leupaxin |
|
|
ISO |
1 |
215,885,954 |
215,920,253 |
RGD:1624291 |
RGD |
| G |
Lpxn |
leupaxin |
|
|
IEA |
1 |
215,885,954 |
215,920,253 |
RGD:1600115 |
ENSEMBL |
| G |
Lpxn |
leupaxin |
|
|
IEA |
1 |
215,885,954 |
215,920,253 |
RGD:1600115 |
ENSEMBL |
negative regulation of brain-derived neurotrophic factor-activated receptor activity
|
| G |
Fam72a |
family with sequence similarity 72, member A |
|
|
IDA |
13 |
44,453,797 |
44,469,514 |
|
MGI |
negative regulation of epidermal growth factor receptor signaling pathway
|
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
|
ISO |
1 |
79,091,412 |
79,108,189 |
RGD:1624291 |
RGD |
| G |
Dab2ip |
DAB2 interacting protein |
|
|
IDA |
3 |
14,667,700 |
14,840,625 |
RGD:632628 |
BHF-UCL |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:1624291 |
RGD |
| G |
Nup62 |
nucleoporin 62 |
|
|
ISO |
1 |
95,288,019 |
95,303,545 |
RGD:1624291 |
RGD |
| G |
Nup62 |
nucleoporin 62 |
|
|
IEA |
1 |
95,288,019 |
95,303,545 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
|
IMP |
5 |
138,671,725 |
138,739,002 |
RGD:1642757 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Tfap2a |
transcription factor AP-2 alpha |
|
|
ISO |
17 |
30,017,580 |
30,034,852 |
RGD:1624291 |
RGD |
| G |
Tfap2a |
transcription factor AP-2 alpha |
|
|
IEA |
17 |
30,017,580 |
30,034,852 |
RGD:1600115 |
ENSEMBL |
| G |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
|
|
ISO |
14 |
82,158,573 |
82,245,071 |
RGD:1624291 |
RGD |
negative regulation of epidermal growth factor-activated receptor activity
|
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
|
IEA |
1 |
79,091,412 |
79,108,189 |
RGD:1600115 |
ENSEMBL |
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
|
ISO |
1 |
79,091,412 |
79,108,189 |
RGD:1624291 |
RGD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:1624291 |
RGD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISS |
5 |
168,012,683 |
168,025,963 |
RGD:1600115 |
UniProtKB |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISS |
5 |
168,012,683 |
168,025,963 |
RGD:1600115 |
UniProtKB |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
IDA |
5 |
168,012,683 |
168,025,963 |
|
UniProtKB |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISS |
5 |
168,012,683 |
168,025,963 |
RGD:1600115 |
UniProtKB |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
|
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:1624291 |
RGD |
| G |
Psen1 |
presenilin 1 |
|
|
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:1624291 |
RGD |
| G |
Psen1 |
presenilin 1 |
|
|
IEA |
6 |
107,737,543 |
107,776,357 |
RGD:1600115 |
ENSEMBL |
| G |
Psen2 |
presenilin 2 |
|
|
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:1624291 |
RGD |
| G |
Socs4 |
suppressor of cytokine signaling 4 |
|
|
IEA |
15 |
23,229,083 |
23,243,568 |
RGD:1600115 |
ENSEMBL |
| G |
Socs4 |
suppressor of cytokine signaling 4 |
|
|
ISO |
15 |
23,229,083 |
23,243,568 |
RGD:1624291 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
ISO |
6 |
10,552,177 |
10,582,783 |
RGD:1624291 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
IEA |
6 |
10,552,177 |
10,582,783 |
RGD:1600115 |
ENSEMBL |
| G |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
|
|
IEA |
14 |
82,158,573 |
82,245,071 |
RGD:1600115 |
ENSEMBL |
| G |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
|
|
ISO |
14 |
82,158,573 |
82,245,071 |
RGD:1624291 |
RGD |
| G |
Zgpat |
zinc finger, CCCH-type with G patch domain |
|
|
ISO |
3 |
170,505,701 |
170,521,996 |
RGD:1624291 |
RGD |
| G |
Zgpat |
zinc finger, CCCH-type with G patch domain |
|
|
ISS |
3 |
170,505,701 |
170,521,996 |
RGD:1600115 |
UniProtKB |
negative regulation of fibroblast growth factor receptor signaling pathway
|
| G |
Gpc1 |
glypican 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Gpc1 |
glypican 1 |
|
|
ISS |
|
|
|
RGD:1600115 |
UniProtKB |
| G |
Gpc1 |
glypican 1 |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Ngfr |
nerve growth factor receptor |
|
|
ISO |
10 |
84,262,804 |
84,281,006 |
RGD:1624291 |
RGD |
| G |
Ngfr |
nerve growth factor receptor |
|
|
IEA |
10 |
84,262,804 |
84,281,006 |
RGD:1600115 |
ENSEMBL |
| G |
Spry1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
|
|
IEA |
2 |
124,213,692 |
124,218,334 |
RGD:1600115 |
ENSEMBL |
| G |
Spry2 |
sprouty homolog 2 (Drosophila) |
|
|
ISO |
15 |
90,009,109 |
90,011,940 |
RGD:1624291 |
RGD |
| G |
Spry2 |
sprouty homolog 2 (Drosophila) |
|
|
ISO |
15 |
90,009,109 |
90,011,940 |
RGD:1624291 |
RGD |
| G |
Spry2 |
sprouty homolog 2 (Drosophila) |
|
|
IEA |
15 |
90,009,109 |
90,011,940 |
RGD:1600115 |
ENSEMBL |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
IEA |
5 |
5,582,896 |
5,748,106 |
RGD:1600115 |
ENSEMBL |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISS |
5 |
5,582,896 |
5,748,106 |
RGD:1600115 |
UniProtKB |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISS |
5 |
5,582,896 |
5,748,106 |
RGD:1600115 |
UniProtKB |
| G |
Sulf2 |
sulfatase 2 |
|
|
ISO |
3 |
157,197,256 |
157,298,389 |
RGD:1624291 |
RGD |
| G |
Sulf2 |
sulfatase 2 |
|
|
ISO |
3 |
157,197,256 |
157,298,389 |
RGD:1624291 |
RGD |
| G |
Sulf2 |
sulfatase 2 |
|
|
IEA |
3 |
157,197,256 |
157,298,389 |
RGD:1600115 |
ENSEMBL |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
|
ISO |
1 |
262,031,823 |
262,226,710 |
RGD:1624291 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
IEA |
5 |
156,064,371 |
156,083,198 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
IEA |
16 |
3,782,025 |
3,799,625 |
RGD:1600115 |
ENSEMBL |
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation
|
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:1624291 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISS |
17 |
79,991,587 |
80,011,574 |
RGD:1600115 |
UniProtKB |
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation
|
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:1624291 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISS |
17 |
79,991,587 |
80,011,574 |
RGD:1600115 |
UniProtKB |
negative regulation of insulin receptor signaling pathway
|
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
|
IDA |
11 |
80,330,615 |
80,336,658 |
RGD:632173 |
RGD |
| G |
Ankrd26 |
ankyrin repeat domain 26 |
|
|
ISO |
4 |
154,801,803 |
154,871,524 |
RGD:1624291 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:1624291 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:1624291 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
IEA |
1 |
21,223,678 |
21,287,411 |
RGD:1600115 |
ENSEMBL |
| G |
Gpr21 |
G protein-coupled receptor 21 |
|
|
ISO |
3 |
17,271,893 |
17,274,816 |
RGD:1624291 |
RGD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
|
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:1624291 |
RGD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
|
IEA |
14 |
92,814,797 |
92,911,442 |
RGD:1600115 |
ENSEMBL |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
|
IMP |
3 |
46,832,380 |
46,952,670 |
RGD:2307023 |
RGD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
|
IDA |
3 |
46,832,380 |
46,952,670 |
RGD:61620 |
RGD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
|
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEA |
3 |
116,964,422 |
116,970,867 |
RGD:1600115 |
ENSEMBL |
| G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
|
|
ISO |
10 |
62,953,425 |
62,971,016 |
RGD:1624291 |
RGD |
| G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
|
|
ISO |
10 |
62,953,425 |
62,971,016 |
RGD:1624291 |
RGD |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
|
IMP |
1 |
159,278,131 |
159,292,740 |
RGD:2312443 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IMP |
9 |
81,585,251 |
81,638,071 |
|
BHF-UCL |
| G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
|
ISO |
1 |
228,748,121 |
228,868,261 |
RGD:1624291 |
RGD |
| G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
|
IEA |
1 |
228,748,121 |
228,868,261 |
RGD:1600115 |
ENSEMBL |
| G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
|
|
ISO |
9 |
83,412,797 |
83,429,039 |
RGD:1624291 |
RGD |
| G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
|
|
IEA |
9 |
83,412,797 |
83,429,039 |
RGD:1600115 |
ENSEMBL |
| G |
Prkca |
protein kinase C, alpha |
|
|
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:1624291 |
RGD |
| G |
Prkcb |
protein kinase C, beta |
|
|
IDA |
1 |
181,117,512 |
181,459,856 |
|
UniProtKB |
| G |
Prkcd |
protein kinase C, delta |
|
|
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:1624291 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IEA |
16 |
5,954,218 |
5,975,743 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcq |
protein kinase C, theta |
|
|
ISO |
17 |
78,486,998 |
78,566,741 |
RGD:1624291 |
RGD |
| G |
Prkcq |
protein kinase C, theta |
|
|
IEA |
17 |
78,486,998 |
78,566,741 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcq |
protein kinase C, theta |
|
|
ISS |
17 |
78,486,998 |
78,566,741 |
RGD:1600115 |
UniProtKB |
| G |
Prkcz |
protein kinase C, zeta |
|
|
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:1624291 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
IEA |
5 |
172,061,825 |
172,172,793 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
|
ISO |
1 |
195,263,489 |
195,303,249 |
RGD:1624291 |
RGD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
|
IDA |
1 |
195,263,489 |
195,303,249 |
|
UniProtKB |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
|
IMP |
5 |
138,671,725 |
138,739,002 |
RGD:1642757 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
IMP |
1 |
208,262,669 |
208,273,148 |
RGD:2298860 |
RGD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
|
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:1624291 |
RGD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
|
IMP |
10 |
76,657,024 |
76,698,088 |
|
UniProtKB |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
ISO |
10 |
4,819,971 |
4,820,609 |
RGD:1624291 |
RGD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
IEA |
10 |
4,819,971 |
4,820,609 |
RGD:1600115 |
ENSEMBL |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:1624291 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
IEA |
10 |
107,958,468 |
107,959,330 |
RGD:1600115 |
ENSEMBL |
| G |
Ybx1 |
Y box binding protein 1 |
|
|
IMP |
5 |
139,859,176 |
139,875,840 |
RGD:727501 |
RGD |
negative regulation of Kit signaling pathway
|
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
ISO |
12 |
27,497,545 |
27,525,385 |
RGD:1624291 |
RGD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
IEA |
12 |
27,497,545 |
27,525,385 |
RGD:1600115 |
ENSEMBL |
negative regulation of platelet-derived growth factor receptor signaling pathway
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:1624291 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:1624291 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:1600115 |
UniProtKB |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:1600115 |
UniProtKB |
| G |
Apod |
apolipoprotein D |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apod |
apolipoprotein D |
|
|
ISS |
|
|
|
RGD:1600115 |
UniProtKB |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
|
IMP |
1 |
159,278,131 |
159,292,740 |
RGD:1626126 |
RGD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
IEA |
1 |
77,234,538 |
77,236,921 |
RGD:1600115 |
ENSEMBL |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:1624291 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
|
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:1624291 |
RGD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:1624291 |
RGD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
IEA |
4 |
89,613,731 |
89,722,807 |
RGD:1600115 |
ENSEMBL |
negative regulation of T cell receptor signaling pathway
|
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
|
ISO |
11 |
49,690,402 |
49,856,762 |
RGD:1624291 |
RGD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
|
IEA |
11 |
49,690,402 |
49,856,762 |
RGD:1600115 |
ENSEMBL |
| G |
Dusp3 |
dual specificity phosphatase 3 |
|
|
ISO |
10 |
91,031,206 |
91,044,858 |
RGD:1624291 |
RGD |
| G |
Dusp3 |
dual specificity phosphatase 3 |
|
|
IBA |
10 |
91,031,206 |
91,044,858 |
RGD:1600115 |
RefGenome |
| G |
Elf1 |
E74-like factor 1 |
|
|
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:1624291 |
RGD |
| G |
Elf1 |
E74-like factor 1 |
|
|
IEA |
15 |
60,793,794 |
60,835,189 |
RGD:1600115 |
ENSEMBL |
| G |
Pawr |
PRKC, apoptosis, WT1, regulator |
|
|
ISO |
7 |
47,040,162 |
47,119,613 |
RGD:1624291 |
RGD |
| G |
Pawr |
PRKC, apoptosis, WT1, regulator |
|
|
IEA |
7 |
47,040,162 |
47,119,613 |
RGD:1600115 |
ENSEMBL |
| G |
Phpt1 |
phosphohistidine phosphatase 1 |
|
|
IEA |
3 |
3,744,947 |
3,746,346 |
RGD:1600115 |
ENSEMBL |
| G |
Phpt1 |
phosphohistidine phosphatase 1 |
|
|
ISO |
3 |
3,744,947 |
3,746,346 |
RGD:1624291 |
RGD |
| G |
Prnp |
prion protein |
|
|
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:1624291 |
RGD |
| G |
Prnp |
prion protein |
|
|
IEA |
3 |
119,676,137 |
119,691,507 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
IEA |
2 |
199,083,186 |
199,144,309 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
ISO |
2 |
199,083,186 |
199,144,309 |
RGD:1624291 |
RGD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:1624291 |
RGD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
IEA |
4 |
160,843,699 |
160,868,856 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
|
ISO |
8 |
47,027,721 |
47,031,857 |
RGD:1624291 |
RGD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
|
ISS |
8 |
47,027,721 |
47,031,857 |
RGD:1600115 |
UniProtKB |
| G |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
|
|
IEA |
20 |
9,583,659 |
9,620,767 |
RGD:1600115 |
ENSEMBL |
negative regulation of vascular endothelial growth factor signaling pathway
|
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISS |
3 |
14,667,700 |
14,840,625 |
RGD:1600115 |
UniProtKB |
| G |
Hrg |
histidine-rich glycoprotein |
|
|
ISO |
11 |
80,248,578 |
80,264,179 |
RGD:1624291 |
RGD |
| G |
Hrg |
histidine-rich glycoprotein |
|
|
ISS |
11 |
80,248,578 |
80,264,179 |
RGD:1600115 |
UniProtKB |
| G |
Xdh |
xanthine dehydrogenase |
|
|
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:1624291 |
RGD |
| G |
Xdh |
xanthine dehydrogenase |
|
|
IEA |
6 |
21,417,685 |
21,590,015 |
RGD:1600115 |
ENSEMBL |
platelet-derived growth factor receptor signaling pathway
|
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
|
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:1624291 |
RGD |
| G |
Arid5b |
AT rich interactive domain 5B (Mrf1 like) |
|
|
ISO |
20 |
21,122,734 |
21,307,034 |
RGD:1624291 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:1624291 |
RGD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
IEA |
19 |
41,646,190 |
41,669,234 |
RGD:1600115 |
ENSEMBL |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
|
ISS |
19 |
41,646,190 |
41,669,234 |
RGD:1600115 |
UniProtKB |
| G |
Bcr |
breakpoint cluster region |
|
|
IDA |
20 |
13,972,773 |
14,097,816 |
RGD:1600511 |
RGD |
| G |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
|
|
ISO |
8 |
124,933,472 |
124,939,576 |
RGD:1624291 |
RGD |
| G |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
|
|
IEA |
8 |
124,933,472 |
124,939,576 |
RGD:1600115 |
ENSEMBL |
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:1624291 |
RGD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
|
IEA |
19 |
28,980,284 |
29,088,877 |
RGD:1600115 |
ENSEMBL |
| G |
Jak2 |
Janus kinase 2 |
|
|
IMP |
1 |
232,915,995 |
232,974,763 |
RGD:1600095 |
RGD |
| G |
Myo1e |
myosin IE |
|
|
ISO |
8 |
74,680,727 |
74,884,376 |
RGD:1624291 |
RGD |
| G |
Nrp1 |
neuropilin 1 |
|
|
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:1624291 |
RGD |
| G |
Nrp1 |
neuropilin 1 |
|
|
IEA |
19 |
58,332,004 |
58,487,686 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:1624291 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:1624291 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:1624291 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISS |
12 |
16,151,045 |
16,172,412 |
RGD:1600115 |
UniProtKB |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
IBA |
12 |
16,151,045 |
16,172,412 |
RGD:1600115 |
RefGenome |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IMP |
7 |
118,244,385 |
118,262,021 |
RGD:2292197 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfc |
platelet derived growth factor C |
|
|
ISO |
2 |
172,635,732 |
172,811,004 |
RGD:1624291 |
RGD |
| G |
Pdgfc |
platelet derived growth factor C |
|
|
ISO |
2 |
172,635,732 |
172,811,004 |
RGD:1624291 |
RGD |
| G |
Pdgfc |
platelet derived growth factor C |
|
|
IEA |
2 |
172,635,732 |
172,811,004 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:1624291 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:1624291 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:1624291 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISS |
14 |
35,369,422 |
35,418,126 |
RGD:1600115 |
UniProtKB |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:1624291 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:1624291 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:1624291 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:1624291 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
IEA |
16 |
73,711,323 |
73,736,328 |
RGD:1600115 |
ENSEMBL |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
|
ISO |
1 |
190,187,202 |
190,238,309 |
RGD:1624291 |
RGD |
| G |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
|
IEA |
1 |
190,187,202 |
190,238,309 |
RGD:1600115 |
ENSEMBL |
| G |
Pten |
phosphatase and tensin homolog |
|
|
IDA |
1 |
236,771,027 |
236,837,261 |
RGD:1358422 |
RGD |
| G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
|
|
ISO |
3 |
74,796,764 |
74,935,540 |
RGD:1624291 |
RGD |
| G |
Rgs14 |
regulator of G-protein signaling 14 |
|
|
IDA |
17 |
15,293,100 |
15,307,162 |
|
UniProtKB |
| G |
Sgpl1 |
sphingosine-1-phosphate lyase 1 |
|
|
ISO |
20 |
28,459,734 |
28,505,017 |
RGD:1624291 |
RGD |
| G |
Sgpl1 |
sphingosine-1-phosphate lyase 1 |
|
|
IEA |
20 |
28,459,734 |
28,505,017 |
RGD:1600115 |
ENSEMBL |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IEP |
3 |
148,157,256 |
148,170,524 |
RGD:1580850 |
RGD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
|
IEA |
2 |
155,312,341 |
155,339,357 |
RGD:1600115 |
ENSEMBL |
| G |
Txnip |
thioredoxin interacting protein |
|
|
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:1624291 |
RGD |
| G |
Txnip |
thioredoxin interacting protein |
|
|
IEA |
2 |
191,356,954 |
191,360,757 |
RGD:1600115 |
ENSEMBL |
| G |
Zfand5 |
zinc finger, AN1-type domain 5 |
|
|
ISO |
1 |
224,442,733 |
224,448,701 |
RGD:1624291 |
RGD |
| G |
Zfand5 |
zinc finger, AN1-type domain 5 |
|
|
IEA |
1 |
224,442,733 |
224,448,701 |
RGD:1600115 |
ENSEMBL |
positive regulation of antigen receptor-mediated signaling pathway
|
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISS |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
UniProtKB |
positive regulation of B cell receptor signaling pathway
|
| G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
|
|
ISO |
7 |
121,019,642 |
121,038,935 |
RGD:1624291 |
RGD |
| G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
|
|
IEA |
7 |
121,019,642 |
121,038,935 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcb |
protein kinase C, beta |
|
|
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:1624291 |
RGD |
| G |
Prkcb |
protein kinase C, beta |
|
|
IEA |
1 |
181,117,512 |
181,459,856 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcb |
protein kinase C, beta |
|
|
ISS |
1 |
181,117,512 |
181,459,856 |
RGD:1600115 |
UniProtKB |
| G |
Prkch |
protein kinase C, eta |
|
|
ISO |
6 |
96,069,354 |
96,281,790 |
RGD:1624291 |
RGD |
| G |
Prkch |
protein kinase C, eta |
|
|
ISS |
6 |
96,069,354 |
96,281,790 |
RGD:1600115 |
UniProtKB |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway
|
| G |
Myo1c |
myosin IC |
|
|
ISO |
10 |
62,990,673 |
63,006,974 |
RGD:1624291 |
RGD |
| G |
Myo1c |
myosin IC |
|
|
IEA |
10 |
62,990,673 |
63,006,974 |
RGD:1600115 |
ENSEMBL |
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway
|
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:1624291 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
IEA |
14 |
35,369,422 |
35,418,126 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:1624291 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
IEA |
18 |
57,014,475 |
57,053,581 |
RGD:1600115 |
ENSEMBL |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:1624291 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
IEA |
9 |
10,520,730 |
10,536,071 |
RGD:1600115 |
ENSEMBL |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway
|
| G |
Hspb1 |
heat shock protein 1 |
|
|
IEA |
12 |
21,911,223 |
21,912,784 |
RGD:1600115 |
ENSEMBL |
| G |
Hspb1 |
heat shock protein 1 |
|
|
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:1624291 |
RGD |
| G |
Prkd1 |
protein kinase D1 |
|
|
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:1624291 |
RGD |
| G |
Prkd1 |
protein kinase D1 |
|
|
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:1624291 |
RGD |
| G |
Prkd1 |
protein kinase D1 |
|
|
IEA |
6 |
70,364,135 |
70,682,006 |
RGD:1600115 |
ENSEMBL |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
IEA |
1 |
77,168,290 |
77,197,277 |
RGD:1600115 |
ENSEMBL |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
IEA |
9 |
10,520,730 |
10,536,071 |
RGD:1600115 |
ENSEMBL |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:1624291 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:1624291 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:1624291 |
RGD |
positive regulation of epidermal growth factor receptor signaling pathway
|
| G |
Afap1l2 |
actin filament associated protein 1-like 2 |
|
|
ISO |
1 |
263,220,056 |
263,256,132 |
RGD:1624291 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:1624291 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IEA |
19 |
54,738,556 |
54,750,349 |
RGD:1600115 |
ENSEMBL |
| G |
Esr1 |
estrogen receptor 1 |
|
|
IMP |
1 |
35,523,680 |
35,759,891 |
RGD:5128669 |
RGD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
|
IMP |
6 |
98,691,167 |
98,775,299 |
RGD:5128669 |
RGD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
|
IMP |
13 |
77,472,950 |
77,480,210 |
RGD:2315731 |
RGD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
|
IMP |
12 |
15,718,615 |
15,719,893 |
RGD:4892084 |
RGD |
| G |
Pde6h |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
|
|
ISO |
4 |
174,009,860 |
174,014,405 |
RGD:1624291 |
RGD |
| G |
Pde6h |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
|
|
IEA |
4 |
174,009,860 |
174,014,405 |
RGD:1600115 |
ENSEMBL |
| G |
Sos1 |
Son of sevenless homolog 1 (Drosophila) |
|
|
IEP |
6 |
3,308,778 |
3,390,661 |
RGD:1581110 |
RGD |
positive regulation of epidermal growth factor-activated receptor activity
|
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:1624291 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:1624291 |
RGD |
| G |
Adora1 |
adenosine A1 receptor |
|
|
IMP |
13 |
47,160,292 |
47,192,804 |
RGD:2317913 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Egf |
epidermal growth factor |
|
|
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:1624291 |
RGD |
| G |
Epgn |
epithelial mitogen |
|
|
ISO |
14 |
18,573,036 |
18,579,934 |
RGD:1624291 |
RGD |
| G |
Epgn |
epithelial mitogen |
|
|
ISS |
14 |
18,573,036 |
18,579,934 |
RGD:1600115 |
HGNC |
| G |
Ereg |
epiregulin |
|
|
IDA |
14 |
18,521,069 |
18,534,844 |
RGD:632743 |
UniProtKB |
| G |
Fbxw7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
|
|
ISO |
2 |
176,675,226 |
176,750,737 |
RGD:1624291 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:1624291 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
4 |
120,355,649 |
120,437,772 |
RGD:1600115 |
HGNC |
positive regulation of ERBB signaling pathway
|
| G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
positive regulation of Fc receptor mediated stimulatory signaling pathway
|
| G |
Cd226 |
CD226 molecule |
|
|
ISO |
18 |
86,064,574 |
86,157,909 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
IMP |
5 |
16,933,111 |
17,054,564 |
RGD:1578516 |
RGD |
positive regulation of fibroblast growth factor receptor signaling pathway
|
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:1624291 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:1624291 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
IBA |
8 |
125,978,161 |
125,987,670 |
RGD:1600115 |
RefGenome |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
|
ISO |
14 |
72,242,271 |
72,243,353 |
RGD:1624291 |
RGD |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
|
IEA |
14 |
72,242,271 |
72,243,353 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
|
|
IEA |
1 |
241,188,007 |
241,190,012 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
|
|
ISO |
1 |
241,188,007 |
241,190,012 |
RGD:1624291 |
RGD |
| G |
Nptn |
neuroplastin |
|
|
IDA |
8 |
62,389,893 |
62,466,128 |
RGD:2325174 |
UniProtKB |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEA |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
ENSEMBL |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISS |
1 |
77,168,290 |
77,197,277 |
RGD:1600115 |
UniProtKB |
positive regulation of insulin receptor signaling pathway
|
| G |
Adipor1 |
adiponectin receptor 1 |
|
|
IMP |
13 |
47,358,625 |
47,379,565 |
RGD:2317907 |
RGD |
| G |
Fam132a |
family with sequence similarity 132, member A |
|
|
ISO |
5 |
172,801,076 |
172,805,451 |
RGD:1624291 |
RGD |
| G |
Fam132a |
family with sequence similarity 132, member A |
|
|
IEA |
5 |
172,801,076 |
172,805,451 |
RGD:1600115 |
ENSEMBL |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:1624291 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:1624291 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEA |
1 |
202,906,624 |
202,915,231 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IMP |
9 |
81,585,251 |
81,638,071 |
|
BHF-UCL |
| G |
Lep |
leptin |
|
|
IDA |
4 |
55,943,837 |
55,945,938 |
RGD:5128575 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
IMP |
5 |
172,061,825 |
172,172,793 |
|
UniProtKB |
| G |
Sirt1 |
sirtuin 1 |
|
|
IEA |
20 |
25,675,302 |
25,686,494 |
RGD:1600115 |
ENSEMBL |
| G |
Sirt1 |
sirtuin 1 |
|
|
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:1624291 |
RGD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IDA |
3 |
148,157,256 |
148,170,524 |
RGD:1581139 |
RGD |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway
|
| G |
Fgf21 |
fibroblast growth factor 21 |
|
|
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:1624291 |
RGD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
|
IEA |
1 |
96,082,475 |
96,083,718 |
RGD:1600115 |
ENSEMBL |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
|
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:1624291 |
RGD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
|
IEA |
4 |
163,468,604 |
163,476,325 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:1624291 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
IEA |
16 |
70,869,974 |
70,910,045 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
IEA |
14 |
82,683,191 |
82,697,229 |
RGD:1600115 |
ENSEMBL |
| G |
Kl |
Klotho |
|
|
ISO |
12 |
3,732,712 |
3,772,371 |
RGD:1624291 |
RGD |
| G |
Kl |
Klotho |
|
|
IEA |
12 |
3,732,712 |
3,772,371 |
RGD:1600115 |
ENSEMBL |
| G |
Klb |
klotho beta |
|
|
ISO |
14 |
45,598,875 |
45,650,432 |
RGD:1624291 |
RGD |
positive regulation of platelet-derived growth factor receptor signaling pathway
|
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:1624291 |
RGD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
|
IEA |
2 |
218,371,050 |
218,382,645 |
RGD:1600115 |
ENSEMBL |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISO |
16 |
81,348,678 |
81,358,991 |
RGD:1624291 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
IEA |
16 |
81,348,678 |
81,358,991 |
RGD:1600115 |
ENSEMBL |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IEP |
3 |
148,157,256 |
148,170,524 |
|
UniProtKB |
positive regulation of T cell receptor signaling pathway
|
| G |
Ada |
adenosine deaminase |
|
|
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:1624291 |
RGD |
| G |
Ada |
adenosine deaminase |
|
|
IEA |
3 |
154,636,530 |
154,660,637 |
RGD:1600115 |
ENSEMBL |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
|
ISO |
10 |
87,925,093 |
87,936,325 |
RGD:1624291 |
RGD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
|
IEA |
10 |
87,925,093 |
87,936,325 |
RGD:1600115 |
ENSEMBL |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
|
IEA |
1 |
79,613,736 |
79,628,887 |
RGD:1600115 |
ENSEMBL |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
|
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISS |
1 |
77,168,290 |
77,197,277 |
RGD:1600115 |
UniProtKB |
| G |
Trat1 |
T cell receptor associated transmembrane adaptor 1 |
|
|
ISO |
11 |
53,279,300 |
53,321,892 |
RGD:1624291 |
RGD |
| G |
Trat1 |
T cell receptor associated transmembrane adaptor 1 |
|
|
IEA |
11 |
53,279,300 |
53,321,892 |
RGD:1600115 |
ENSEMBL |
positive regulation of vascular endothelial growth factor signaling pathway
|
| G |
Myo1c |
myosin IC |
|
|
ISO |
10 |
62,990,673 |
63,006,974 |
RGD:1624291 |
RGD |
| G |
Myo1c |
myosin IC |
|
|
IEA |
10 |
62,990,673 |
63,006,974 |
RGD:1600115 |
ENSEMBL |
receptor guanylyl cyclase signaling pathway
|
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
|
ISO |
7 |
10,203,112 |
10,271,719 |
RGD:1624291 |
RGD |
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
|
IEA |
7 |
10,203,112 |
10,271,719 |
RGD:1600115 |
ENSEMBL |
| G |
Nppa |
natriuretic peptide A |
|
|
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:1624291 |
RGD |
| G |
Nppa |
natriuretic peptide A |
|
|
ISS |
5 |
165,074,518 |
165,075,827 |
RGD:1600115 |
UniProtKB |
| G |
Nppa |
natriuretic peptide A |
|
|
IDA |
5 |
165,074,518 |
165,075,827 |
|
MGI |
| G |
Nppb |
natriuretic peptide B |
|
|
ISO |
5 |
165,062,348 |
165,063,650 |
RGD:1624291 |
RGD |
| G |
Nppb |
natriuretic peptide B |
|
|
ISS |
5 |
165,062,348 |
165,063,650 |
RGD:1600115 |
UniProtKB |
| G |
Nppc |
natriuretic peptide C |
|
|
ISO |
9 |
85,434,254 |
85,438,454 |
RGD:1624291 |
RGD |
| G |
Nppc |
natriuretic peptide C |
|
|
IDA |
9 |
85,434,254 |
85,438,454 |
|
MGI |
| G |
Nppc |
natriuretic peptide C |
|
|
ISS |
9 |
85,434,254 |
85,438,454 |
RGD:1600115 |
UniProtKB |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
|
ISO |
2 |
182,724,916 |
182,740,242 |
RGD:1624291 |
RGD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
|
IEA |
2 |
182,724,916 |
182,740,242 |
RGD:1600115 |
ENSEMBL |
| G |
Npr2 |
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
|
ISO |
5 |
60,107,563 |
60,127,960 |
RGD:1624291 |
RGD |
| G |
Npr2 |
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
|
IEA |
5 |
60,107,563 |
60,127,960 |
RGD:1600115 |
ENSEMBL |
regulation of B cell receptor signaling pathway
|
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
IEA |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
ENSEMBL |
regulation of epidermal growth factor receptor signaling pathway
|
| G |
Cdh13 |
cadherin 13 |
|
|
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:1624291 |
RGD |
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
| G |
Rhbdf1 |
rhomboid 5 homolog 1 (Drosophila) |
|
|
ISO |
10 |
15,653,948 |
15,666,851 |
RGD:1624291 |
RGD |
| G |
Rhbdf1 |
rhomboid 5 homolog 1 (Drosophila) |
|
|
ISS |
10 |
15,653,948 |
15,666,851 |
RGD:1600115 |
UniProtKB |
regulation of epidermal growth factor-activated receptor activity
|
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
App |
amyloid beta (A4) precursor protein |
|
|
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:1624291 |
RGD |
| G |
App |
amyloid beta (A4) precursor protein |
|
|
ISS |
11 |
24,457,855 |
24,693,851 |
RGD:1600115 |
UniProtKB |
| G |
Psen1 |
presenilin 1 |
|
|
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:1624291 |
RGD |
| G |
Psen2 |
presenilin 2 |
|
|
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:1624291 |
RGD |
| G |
Psen2 |
presenilin 2 |
|
|
IEA |
13 |
95,934,674 |
95,951,836 |
RGD:1600115 |
ENSEMBL |
regulation of Fc receptor mediated stimulatory signaling pathway
|
| G |
Csk |
c-src tyrosine kinase |
|
|
IDA |
8 |
61,381,336 |
61,386,013 |
RGD:2303720 |
RGD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
|
IMP |
8 |
97,206,388 |
97,226,725 |
RGD:2303650 |
UniProtKB |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
ISO |
12 |
27,497,545 |
27,525,385 |
RGD:1624291 |
RGD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
ISO |
12 |
27,497,545 |
27,525,385 |
RGD:1624291 |
RGD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
IEA |
12 |
27,497,545 |
27,525,385 |
RGD:1600115 |
ENSEMBL |
regulation of fibroblast growth factor receptor signaling pathway
|
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
|
IBA |
7 |
36,893,264 |
36,897,494 |
RGD:1600115 |
RefGenome |
| G |
Fam20c |
family with sequence similarity 20, member C |
|
|
IEA |
12 |
16,340,407 |
16,399,325 |
RGD:1600115 |
ENSEMBL |
| G |
Fam20c |
family with sequence similarity 20, member C |
|
|
ISO |
12 |
16,340,407 |
16,399,325 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:1624291 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
IEA |
1 |
189,482,975 |
189,589,279 |
RGD:1600115 |
ENSEMBL |
| G |
Hhip |
Hedgehog-interacting protein |
|
|
ISO |
19 |
29,752,595 |
29,840,439 |
RGD:1624291 |
RGD |
| G |
Hhip |
Hedgehog-interacting protein |
|
|
IEA |
19 |
29,752,595 |
29,840,439 |
RGD:1600115 |
ENSEMBL |
| G |
Runx2 |
runt-related transcription factor 2 |
|
|
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:1624291 |
RGD |
| G |
Sulf1 |
sulfatase 1 |
|
|
ISO |
5 |
5,582,896 |
5,748,106 |
RGD:1624291 |
RGD |
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation
|
| G |
Nog |
noggin |
|
|
ISO |
10 |
77,689,244 |
77,690,871 |
RGD:1624291 |
RGD |
| G |
Nog |
noggin |
|
|
IEA |
10 |
77,689,244 |
77,690,871 |
RGD:1600115 |
ENSEMBL |
regulation of insulin receptor signaling pathway
|
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
|
ISO |
X |
89,721,369 |
89,766,218 |
RGD:1624291 |
RGD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
|
IEA |
X |
89,721,369 |
89,766,218 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
|
IMP |
3 |
159,070,473 |
159,116,792 |
RGD:1625241 |
RGD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
|
ISO |
10 |
13,848,210 |
13,883,189 |
RGD:1624291 |
RGD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
|
IBA |
10 |
13,848,210 |
13,883,189 |
RGD:1600115 |
RefGenome |
| G |
Tsc2_v1 |
tuberous sclerosis 2, variant 1 |
|
|
IBA |
|
|
|
RGD:1600115 |
RefGenome |
| G |
Tsc2_v2 |
tuberous sclerosis 2, variant 2 |
|
|
IBA |
|
|
|
RGD:1600115 |
RefGenome |
regulation of platelet-derived growth factor receptor signaling pathway
|
| G |
Fshr |
follicle stimulating hormone receptor |
|
|
ISO |
6 |
12,925,894 |
13,161,215 |
RGD:1624291 |
RGD |
regulation of T cell receptor signaling pathway
|
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:1624291 |
RGD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
|
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:1624291 |
RGD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
|
IEA |
5 |
148,707,505 |
148,718,296 |
RGD:1600115 |
ENSEMBL |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:1624291 |
RGD |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
IEA |
18 |
61,708,388 |
61,760,004 |
RGD:1600115 |
ENSEMBL |
| G |
Rc3h1 |
ring finger and CCCH-type domains 1 |
|
|
ISO |
13 |
76,493,343 |
76,530,107 |
RGD:1624291 |
RGD |
stimulatory C-type lectin receptor signaling pathway
|
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
|
ISO |
4 |
166,857,685 |
166,864,221 |
RGD:1624291 |
RGD |
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
|
IEA |
4 |
166,857,685 |
166,864,221 |
RGD:1600115 |
ENSEMBL |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
|
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:1624291 |
RGD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
|
IEA |
4 |
166,914,786 |
166,922,659 |
RGD:1600115 |
ENSEMBL |
T cell receptor signaling pathway
|
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:1624291 |
RGD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISS |
2 |
244,116,880 |
244,126,393 |
RGD:1600115 |
UniProtKB |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
|
ISO |
7 |
137,384,752 |
137,394,283 |
RGD:1624291 |
RGD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
|
IEA |
7 |
137,384,752 |
137,394,283 |
RGD:1600115 |
ENSEMBL |
| G |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
|
|
ISO |
3 |
33,934,478 |
34,072,070 |
RGD:1624291 |
RGD |
| G |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
|
|
ISO |
3 |
33,934,478 |
34,072,070 |
RGD:1624291 |
RGD |
| G |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
|
|
IEA |
3 |
33,934,478 |
34,072,070 |
RGD:1600115 |
ENSEMBL |
| G |
Cd247 |
Cd247 molecule |
|
|
ISO |
13 |
81,515,383 |
81,594,699 |
RGD:1624291 |
RGD |
| G |
Cd247 |
Cd247 molecule |
|
|
IEA |
13 |
81,515,383 |
81,594,699 |
RGD:1600115 |
ENSEMBL |
| G |
Cd3e |
CD3 molecule, epsilon |
|
|
ISO |
8 |
47,947,257 |
47,958,419 |
RGD:1624291 |
RGD |
| G |
Cd3e |
CD3 molecule, epsilon |
|
|
IEA |
8 |
47,947,257 |
47,958,419 |
RGD:1600115 |
ENSEMBL |
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
|
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:1624291 |
RGD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
|
IEA |
20 |
43,501,853 |
43,695,567 |
RGD:1600115 |
ENSEMBL |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:1624291 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISS |
17 |
79,991,587 |
80,011,574 |
RGD:1600115 |
UniProtKB |
| G |
Itk |
IL2-inducible T-cell kinase |
|
|
ISO |
10 |
31,455,982 |
31,518,075 |
RGD:1624291 |
RGD |
| G |
Lime1 |
Lck interacting transmembrane adaptor 1 |
|
|
IEA |
3 |
170,522,420 |
170,524,743 |
RGD:1600115 |
InterPro |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
IEA |
18 |
61,708,388 |
61,760,004 |
RGD:1600115 |
ENSEMBL |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:1624291 |
RGD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:1624291 |
RGD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
IEA |
11 |
85,968,732 |
86,030,387 |
RGD:1600115 |
ENSEMBL |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
|
ISO |
3 |
151,522,949 |
151,553,998 |
RGD:1624291 |
RGD |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
|
IEA |
3 |
151,522,949 |
151,553,998 |
RGD:1600115 |
ENSEMBL |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
|
ISO |
19 |
47,875,572 |
47,947,573 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:1624291 |
RGD |
| G |
Prkd2 |
protein kinase D2 |
|
|
IEA |
1 |
77,168,290 |
77,197,277 |
RGD:1600115 |
ENSEMBL |
| G |
Psen1 |
presenilin 1 |
|
|
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:1624291 |
RGD |
| G |
Psen1 |
presenilin 1 |
|
|
IEA |
6 |
107,737,543 |
107,776,357 |
RGD:1600115 |
ENSEMBL |
| G |
Psen2 |
presenilin 2 |
|
|
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:1624291 |
RGD |
| G |
Psen2 |
presenilin 2 |
|
|
IEA |
13 |
95,934,674 |
95,951,836 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
ISO |
2 |
199,083,186 |
199,144,309 |
RGD:1624291 |
RGD |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
IEA |
2 |
199,083,186 |
199,144,309 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISS |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
UniProtKB |
| G |
Rbck1 |
RanBP-type and C3HC4-type zinc finger containing 1 |
|
|
ISO |
3 |
142,644,156 |
142,660,799 |
RGD:1624291 |
RGD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
|
ISO |
5 |
30,714,817 |
30,745,941 |
RGD:1624291 |
RGD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
|
ISO |
5 |
30,714,817 |
30,745,941 |
RGD:1624291 |
RGD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
|
IEA |
5 |
30,714,817 |
30,745,941 |
RGD:1600115 |
ENSEMBL |
| G |
Rnf31 |
ring finger protein 31 |
|
|
ISO |
15 |
33,727,541 |
33,739,204 |
RGD:1624291 |
RGD |
| G |
Skap1 |
src kinase associated phosphoprotein 1 |
|
|
ISO |
10 |
85,193,804 |
85,507,161 |
RGD:1624291 |
RGD |
| G |
Skap1 |
src kinase associated phosphoprotein 1 |
|
|
IEA |
10 |
85,193,804 |
85,507,161 |
RGD:1600115 |
ENSEMBL |
| G |
Stoml2 |
stomatin (Epb7.2)-like 2 |
|
|
ISO |
5 |
59,518,467 |
59,522,064 |
RGD:1624291 |
RGD |
| G |
Stoml2 |
stomatin (Epb7.2)-like 2 |
|
|
ISS |
5 |
59,518,467 |
59,522,064 |
RGD:1600115 |
UniProtKB |
| G |
Themis2 |
thymocyte selection associated family member 2 |
|
|
ISO |
5 |
152,349,541 |
152,364,664 |
RGD:1624291 |
RGD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
|
IMP |
8 |
47,027,721 |
47,031,857 |
|
UniProtKB |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
|
IEA |
3 |
86,827,582 |
86,847,408 |
RGD:1600115 |
ENSEMBL |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
|
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:1624291 |
RGD |
| G |
Txk |
TXK tyrosine kinase |
|
|
ISO |
14 |
37,867,565 |
37,923,075 |
RGD:1624291 |
RGD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
|
ISO |
7 |
32,719,959 |
32,750,002 |
RGD:1624291 |
RGD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
|
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:1624291 |
RGD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
|
IEA |
9 |
35,693,089 |
35,715,071 |
RGD:1600115 |
ENSEMBL |
transmembrane receptor protein tyrosine kinase signaling pathway
|
| G |
Ahi1 |
Abelson helper integration site 1 |
|
|
ISO |
1 |
16,332,801 |
16,454,055 |
RGD:1624291 |
RGD |
| G |
Ahi1 |
Abelson helper integration site 1 |
|
|
ISS |
1 |
16,332,801 |
16,454,055 |
RGD:1600115 |
UniProtKB |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
|
IEA |
6 |
23,009,061 |
23,730,939 |
RGD:1600115 |
InterPro |
| G |
Angpt1 |
angiopoietin 1 |
|
|
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:1624291 |
RGD |
| G |
Angptl1 |
angiopoietin-like 1 |
|
|
IEA |
13 |
72,039,198 |
72,045,772 |
RGD:1600115 |
ENSEMBL |
| G |
Cbp |
Csk binding protein |
|
|
TAS |
|
|
|
RGD:625637 |
GOC |
| G |
Clnk |
cytokine-dependent hematopoietic cell linker |
|
|
ISO |
14 |
77,226,212 |
77,331,417 |
RGD:1624291 |
RGD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
|
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:1624291 |
RGD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
|
IEA |
18 |
57,080,324 |
57,107,295 |
RGD:1600115 |
ENSEMBL |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
|
ISS |
18 |
57,080,324 |
57,107,295 |
RGD:1600115 |
UniProtKB |
| G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
|
ISO |
8 |
60,610,835 |
60,645,877 |
RGD:1624291 |
RGD |
| G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
|
IEA |
8 |
60,610,835 |
60,645,877 |
RGD:1600115 |
ENSEMBL |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
|
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:1624291 |
RGD |
| G |
Dok1 |
docking protein 1 |
|
|
ISO |
4 |
117,242,746 |
117,245,209 |
RGD:1624291 |
RGD |
| G |
Dok1 |
docking protein 1 |
|
|
IEA |
4 |
117,242,746 |
117,245,209 |
RGD:1600115 |
ENSEMBL |
| G |
Dok2 |
docking protein 2 |
|
|
ISO |
15 |
51,171,277 |
51,174,337 |
RGD:1624291 |
RGD |
| G |
Dok2 |
docking protein 2 |
|
|
ISO |
15 |
51,171,277 |
51,174,337 |
RGD:1624291 |
RGD |
| G |
Dok4 |
docking protein 4 |
|
|
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:1624291 |
RGD |
| G |
Dok4 |
docking protein 4 |
|
|
IEA |
19 |
10,585,647 |
10,596,322 |
RGD:1600115 |
ENSEMBL |
| G |
Dok5 |
docking protein 5 |
|
|
ISO |
3 |
161,654,964 |
161,729,978 |
RGD:1624291 |
RGD |
| G |
Dok5 |
docking protein 5 |
|
|
IEA |
3 |
161,654,964 |
161,729,978 |
RGD:1600115 |
ENSEMBL |
| G |
Ephb2 |
Eph receptor B2 |
|
|
ISO |
5 |
155,423,035 |
155,605,384 |
RGD:1624291 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:1624291 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
IEA |
10 |
87,219,157 |
87,242,919 |
RGD:1600115 |
InterPro |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
|
TAS |
7 |
1,858,057 |
1,877,353 |
RGD:68774 |
RGD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
|
IEA |
7 |
1,858,057 |
1,877,353 |
RGD:1600115 |
InterPro |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
TAS |
9 |
66,843,898 |
67,967,970 |
RGD:629530 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
IEA |
9 |
66,843,898 |
67,967,970 |
RGD:1600115 |
InterPro |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:1624291 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:1624291 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISS |
9 |
66,843,898 |
67,967,970 |
RGD:1600115 |
UniProtKB |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
TAS |
12 |
7,858,092 |
8,035,966 |
RGD:728597 |
RGD |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
|
IEA |
12 |
8,193,629 |
8,268,682 |
RGD:2290270 |
UniProtKB |
| G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
|
|
ISO |
7 |
56,409,863 |
56,490,535 |
RGD:1624291 |
RGD |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
|
ISO |
1 |
154,348,777 |
154,544,906 |
RGD:1624291 |
RGD |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
|
ISS |
1 |
154,348,777 |
154,544,906 |
RGD:1600115 |
GOC |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
|
ISO |
15 |
51,279,770 |
51,371,053 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IEA |
12 |
2,934,967 |
3,087,691 |
RGD:1600115 |
InterPro |
| G |
Insrr |
insulin receptor-related receptor |
|
|
IEA |
2 |
179,857,189 |
179,876,572 |
RGD:1600115 |
InterPro |
| G |
Ltk |
leukocyte receptor tyrosine kinase |
|
|
IEA |
3 |
106,266,245 |
106,273,122 |
RGD:1600115 |
InterPro |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
IEA |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
ENSEMBL |
| G |
Nrg1 |
neuregulin 1 |
|
|
ISO |
16 |
|